1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. The Blockchain Concept
3.3. Potential Applications of Blockchain in Healthcare Industry
3.4. Evolution of Genomic Testing and Whole Genome Sequencing
3.5. The Importance of Genomic Data
3.6. Need for Sharing Genomic Data on Blockchain Platforms
3.6.1. Genomic Data Sharing on Blockchain Platforms
3.6.1.1. Role of Utility Tokens
3.6.1.2. Initial Coin Offerings
3.6.1.3. Role of Compression Tools
3.7. Advantages and Limitations of Sharing Genomic Data on Blockchain Platforms

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Blockchain in Genomic Data Management: List of Industry Players
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Geographical Location
4.2.3. Analysis by Company Size
4.2.4. Analysis by Geographical Location and Year of Establishment
4.2.5. Analysis by Company Size and Geographical Location
4.2.6. Analysis by Type of Business Model
4.2.7. Analysis by Type of Services Offered
4.2.8. Analysis by Type of End-Users
4.2.9. Analysis by Type of Services Offered and Geographical Location
4.2.10. Analysis by Type of Services Offered and End-Users

5. COMPANY PROFILES
5.1. Chapter Overview
5.2. Block23
5.3. DNAtix
5.4. EncrypGen
5.5. Company 4
5.6. Company 5
5.7. Company 6
5.8. Company 7
5.9. Company 8
5.10. Company 9
5.11. Company 10
5.12. Company 11
5.13. Company 12
5.14. Company 13
5.15. Company 14
5.16. Company 15

6. EMERGING TRENDS ON SOCIAL MEDIA
6.1. Chapter Overview
6.2. Blockchain in Genomic Data Management: Trends on Twitter
6.2.1. Historical Trends in Volume of Tweets
6.2.2. Cumulative Year-Wise Activity
6.2.3. Trending Words / Phrases on Twitter
6.2.4. Trending Utility Tokens on Twitter
6.2.5. Popular Players on Twitter
6.2.6. Most Prolific Contributors on Twitter
6.2.7. Sentiment Analysis
6.3. Concluding Remarks

7. STAKEHOLDER NEEDS ANALYSIS
7.1. Chapter Overview
7.2. Needs of Stakeholders (Pharmaceutical Companies / Research Institutes / Data Owners / Government Agenices / Insurers)
7.2.1. Qualitative Analysis of Existing and Future Needs

8. GO-TO-MARKET STRATEGY
8.1. Chapter Overview
8.2. Blockchain in Genomic Data Management: Marketing Strategies
8.2.1. Participation in Global Events
8.2.2. Marketing on Social Media Platforms
8.2.3. Marketing on Online / Print Media Platforms
8.2.4. Adopting Strategic Business Models
8.2.4.1. B2B Business Model
8.2.4.2. B2C Business Model
8.2.4.3. C2B Business Model
8.2.5. Undertaking Promotional Activities
8.3. Concluding Remarks

9. COIN MARKET CAPITALIZATION ANALYSIS
9.1. Chapter Overview
9.2. Methodology
9.2.1. Key Assumptions
9.3. Market Capitalization Analysis for Different Utility Tokens: 3D Bubble Analysis
9.4. Concluding Remarks

10. BLOCKCHAIN IN GENOMIC DATA MANAGEMENT USE CASES AND OPPORTUNITY ASSESSMENT
10.1. Chapter Overview
10.2. Blockchain in Genomic Data Management: Use Cases
10.3. Blockchain in Genomic Data Management: Market Opportunity Assessment
10.3.1. Methodology and Key Assumptions
10.3.2. Blockchain in Genomic Data Management: Market Opportunity, 2018-2030

11. RECENT TRENDS ANALYSIS
11.1. Chapter Overview
11.2. Blockchain in Genomic Data Management: Venture Capital Funding Activity
11.2.1. Types of Funding
11.2.2. List of Funding and Investments
11.2.2.1. Summary of Funding and Investments
11.3. Blockchain in Genomic Data Management: Partnership Activity
11.3.1. List of Partnerships and Collaborations
11.3.1.1. Summary of Partnerships and Collaborations
11.4. Blockchain in Genomic Data Management: Recent News Activity
11.4.1. List of Recent News
11.4.1.1. Analysis by Key Focus Area
11.5. Blockchain in Genomic Data Management: Recent Global Events
11.5.1. List of Recent Global Events
11.5.1.1. Analysis by Year of Occurrence
11.5.1.2. Analysis by Geography
11.5.1.3. Analysis by Type of Event
11.6. Blockchain in Genomic Data Management: Transcripts of Public Discussions
11.6.1. Dennis Grishin, Chief Scientific Officer / Co-founder, Nebula Genomics
11.6.2. Henry Ines, Chief Executive Officer, Shivom
11.6.3. Ofer A Lidsky, Co-founder, Chief Executive Officer and Chief Technology Officer, DNAtix
11.6.4. David Kerr, Chief Executive Officer, Block23
11.6.5. Alex Gorbachev and Nikolay Kulemin, Co-founders, Zenome
11.7. Concluding Remarks

12. EXECUTIVE INSIGHTS
12.1. Chapter Overview
12.2. EncrypGen
12.2.1. Company Snapshot
12.2.2. Interview Transcript: David Koepsell, Chief Executive Officer
12.3. SimplyVital Health
12.3.1. Company Snapshot
12.3.2. Interview Transcript: Jake Dreier, Director of Growth and Operations
12.4. Genomes.io
12.4.1. Company Snapshot
12.4.2. Interview Transcript: Aldo de Pape, Chief Executive Officer and Louis Gooden, Analyst
13. APPENDIX 1: TABULATED DATA
14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Tables
Table 3.1 Applications of Blockchain in Various Industries
Table 3.2 Blockchain in the Healthcare Industry: A Critical Perspective
Table 4.1 Blockchain Genomic Companies: List of Industry Players
Table 4.2 Blockchain Genomic Companies: Information on Blockchain Platform and Utility Token
Table 4.3 Blockchain Genomic Companies: Information on Type of Services Offered
Table 4.4 Blockchain Genomic Companies: Information on Type of End-Users
Table 5.1 Block 23: Company Profile
Table 5.2 DNAtix: Company Profile
Table 5.3 EncrypGen: Company Profile
Table 5.4 Company 4: Profile
Table 5.5 Company 5: Profile
Table 5.6 Company 6: Profile
Table 5.7 Company 7: Profile
Table 5.8 Company 8: Profile
Table 5.9 Company 9: Profile
Table 5.10 Company 10: Profile
Table 5.11 Company 11: Profile
Table 5.12 Company 12: Profile
Table 5.13 Company 13: Profile
Table 5.14 Company 14: Profile
Table 5.15 Company 15: Profile
Table 8.1 Blockchain in Genomic Data Management: Summary of Marketing Strategies
Table 9.1 Blockchain in Genomic Data Management: Comparative Analysis of Utility Tokens
Table 10.1 Blockchain in Genomic Data Management: Use Cases, 2017-Q3 2018
Table 11.1 Blockchain in Genomic Data Management: Funding and Investments, 2017-Q3 2018
Table 11.2 Blockchain in Genomic Data Management: Partnerships and Collaborations, 2017-Q3 2018
Table 11.3 Blockchain in Genomic Data Management: Recent News Activity, 2017- Q3 2018
Table 11.4 Blockchain in Genomic Data Management: Recent Global Events, 2017-H1 2019
Table 12.1 SimplyVital Health: Key Highlights
Table 13.1 Blockchain Genomics Companies: Distribution by Year of Establishment
Table 13.2 Blockchain Genomics Companies: Distribution by Geographical Location
Table 13.3 Blockchain Genomics Companies: Distribution by Size
Table 13.4 Blockchain Genomics Companies: Distribution by Geographical Location and Year of Establishment
Table 13.5 Blockchain Genomics Companies: Distribution by Size and Geographical Location
Table 13.6 Blockchain Genomics Companies: Distribution by Type of Business Model
Table 13.7 Blockchain Genomics Companies: Distribution by Type of Services Offered
Table 13.8 Blockchain Genomics Companies: Distribution by Type of End-Users
Table 13.9 Trends on Social Media: Overview of Keywords
Table 13.10 Trends on Social Media: Cumulative Year-Wise Analysis by Volume, 2015-2018
Table 13.11 Trends on Social Media: Sentiment Analysis
Table 13.12 Go-to-Market Strategy: Commonly Used Social Media Platforms
Table 13.13 Go-to-Market Strategy: Commonly Used Online / Print Media Platforms
Table 13.14 Go-to-Market Strategy: Promotional Activities
Table 13.15 Market Capitalization Analysis for Utility Tokens: 3D Bubble Analysis based on Total Maximum Supply, Circulation Supply and Token Price
Table 13.16 Overall Market Capitalization Value: Likely Scenarios (USD Million)
Table 13.17 Blockchain in Genomic Data Management Market Opportunity, 2018, 2024 and 2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.18 Global Events: Cumulative Year-Wise Trend, 2017-H1 2019
Table 13.19 Global Events: Distribution by Location
Table 13.20 Global Events: Distribution by Type

List of Figures
Figure 3.1 Applications of Blockchain in Various Industries
Figure 3.2 Controversies Related to Sharing Genomic Data
Figure 3.3 Comparison of Genomic Data Handling: Traditional Method Versus Blockchain-Enabled Method
Figure 3.4 Process of Collecting and Sharing Genomic Data on Blockchain Platforms
Figure 3.5 Advantages and Limitations of Sharing Genomic Data on Blockchain Platforms
Figure 4.1 Blockchain Genomics Companies: Distribution by Year of Establishment
Figure 4.2 Blockchain Genomics Companies: Distribution by Geographical Location
Figure 4.3 Blockchain Genomics Companies: Distribution by Size
Figure 4.4 Blockchain Genomics Companies: Distribution by Geographical Location and Year of Establishment
Figure 4.5 Blockchain Genomics Companies: Distribution by Size and Geographical Location
Figure 4.6 Blockchain Genomics Companies: Distribution by Type of Business Model
Figure 4.7 Blockchain Genomics Companies: Distribution by Type of Services Offered
Figure 4.8 Blockchain Genomics Companies: Distribution by Type of End-Users
Figure 4.9 Blockchain Genomics Companies: Heat Map Analysis by Type of Services Offered and Geographical Location
Figure 4.10 Blockchain Genomics Companies: Heat Map Analysis by Type of Services Offered and End-Users
Figure 6.1 Trends on Social Media: Overview of Keywords
Figure 6.2 Trends on Social Media: Historical Activities on Twitter, 2015-2018
Figure 6.3 Trends on Social Media: Cumulative Year-Wise Analysis by Volume, 2015-2018
Figure 6.4 Trends on Social Media: Popular Words / Phrases on Twitter
Figure 6.5 Trends on Social Media: Popular Utility Tokens on Twitter
Figure 6.6 Trends on Social Media: Popular Players on Twitter
Figure 6.7 Trends on Social Media: Most Prolific Contributors
Figure 6.8 Trends on Social Media: Most Influential Contributors
Figure 6.9 Trends on Social Media: Sentiment Analysis
Figure 7.1 Stakeholder Needs Analysis: Summary of Existing and Future Needs
Figure 7.2 Stakeholder Needs Analysis: Qualitative Assessment
Figure 7.3 Stakeholder Needs Analysis: Distribution by Priority
Figure 8.1 Go-to-Market Strategy: Commonly Used Social Media Platforms
Figure 8.2 Go-to-Market Strategy: Commonly Used Online / Print Media Platforms
Figure 8.3 Go-to-Market Strategy: Promotional Activities
Figure 9.1 Market Capitalization Analysis for Utility Tokens: 3D Bubble Analysis based on Total Maximum Supply, Circulation Supply and Token Price
Figure 9.2 Overall Market Capitalization Value: Likely Scenarios (USD Million)
Figure 10.1 Blockchain in Genomic Data Management Market Opportunity, 2018-2030: Base Scenario (USD Million)
Figure 10.2 Blockchain in Genomic Data Management Market Opportunity, 2018, 2024 and 2030: Conservative, Base and Optimistic Scenarios (USD Million)
Figure 11.1 Summary of Funding and Investments, 2017-Q3 2018 (USD Million)
Figure 11.2 Summary of Partnerships and Collaborations, 2017-Q3 2018
Figure 11.3 Recent News Activity: Key Focus Areas
Figure 11.4 Global Events: Cumulative Year-Wise Trend, 2017-H1 2019
Figure 11.5 Global Events: Distribution by Location
Figure 11.6 Global Events: Distribution by Type

The following companies / institutes / government bodies and organizations have been mentioned in this report.

1. 23andMe
2. Ancestry
3. Anorak Ventures
4. ARCH Venture Partners
5. BIGSTER
6. Biologix Group
7. Block23
8. Boost VC
9. Bridge Link Capital
10. Código46
11. CollinStar Capital
12. Ironside Capital
13. DigitalX
14. Discovery Capital Management
15. DNAtix
16. eMQT
17. Emrify
18. EncrypGen
19. Enigma Technologies
20. Fenbushi Capital
21. F-Prime Capital Partners
22. Gene BlockChain
23. Genecoin
24. Genetic Technologies
25. Gene Whisper
26. Genomes.io
27. GnoMine
28. Google
29. GreatPoint Ventures
30. Health Wizz
31. Heartbeat Labs
32. Hemi Ventures
33. Hemisphere Ventures
34. Hikma Ventures
35. Hoperidge Capital
36. Illumina Ventures
37. Khosla Ventures
38. Longenesis
39. LunaDNA
40. Macrogen
41. MapMyGenome
42. Mayfield
43. Med-Metrix
44. MicroVentures
45. Mirae Asset
46. Nebula Genomics
47. Shivom
48. SimplyVital Health
49. SingularityNET
50. Spherity
51. Toro Risk Consulting Group
52. Veritas Technologies
53. Windham Venture Partners
54. WuXi NextCODE Genomics
55. X Genomics
56. YEI Innovation Fund
57. Zenome